Vaccines

Rochester Clinical Research is screening healthy adults ages 18 to 49 for an upcoming smallpox/mpox vaccine study at both our […]

Rochester Clinical Research is now enrolling adults 50-64 years old for a study evaluating an updated mRNA COVID-19 vaccine.

Rochester Clinical Research is enrolling healthy adults ages 50–64 for a COVID-19 vaccine research study (non-mRNA). This study is enrolling

Rochester Clinical Research is currently seeking adults aged 60 and older for an mRNA Norovirus vaccine study.